60
Participants
Start Date
July 10, 2023
Primary Completion Date
February 28, 2026
Study Completion Date
July 31, 2026
Bupivacaine HCl 0.5% Injectable Solution
Will receive 0.5 ml (supratrochlear) to 1.0 ml (supraorbital, auriculotemporal) to 1.25 ml (greater and lesser occipital) for each nerve block.
Methylprednisolone 40 MG Injection
Will receive 10 mg (0.25 ml) mixed with 1.25 ml Bupivacaine 0.5% for each greater and lesser occipital nerve block if MPNB group or 20 mg (0.5 ml) methylprednisolone in each GON if GONB group.
RECRUITING
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER